News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

Are Biofilms the Missing Link in MRSA Decolonization Failure?

March 29, 2017
Article

Device-associated infections due to biofilm-producing methicillin-resistant Staphylococcus aureus (MRSA) have been recently associated with the failure of antibiotic treatment and decolonization measures. The goal of the study by Günther, et al. (2017) was to evaluate the extent to which the formation of biofilms influenced the efficacy of topical decolonization agents or disinfectants such as mupirocin (MUP), octenidine (OCT), chlorhexidine (CHG), polyhexanide (POL), and chloroxylenol (CLO).Bacterial killing in biofilms by the disinfectants and MUP was determined as the reduction [%] in metabolic activity determined by a biofilm viability assay that uses kinetic analysis of metabolic activity. The test substances were diluted in water with standardized hardness (WSH) at 25 °C at the standard concentration as well as half the standard concentration to demonstrate the dilution effects in a practical setting. The tested concentrations were: CHG 1%, 2%; OCT 0.1%, 0.05%; PH 0.04%, 0.02%; and CLO 0.12%, 0.24%. A test organism suspension, 1 mL containing ~1 × 109 bacterial cells/mL, and 1 mL of sterile WSH were mixed and incubated for six different exposure times (15 s, 1, 3, 5, 10 and 20 min) after the test substance was added.Additionally, the bactericidal effects of all substances were tested on planktonic bacteria and measured as the log10 reduction.The disinfectants OCT and CHG showed good efficacy in inhibiting MRSA in biofilms with reduction rates of 94 ± 1% and 91 ± 1%, respectively. POL, on the other hand, had a maximum efficacy of only 81 ± 7%. Compared to the tested disinfectants, MUP showed a significantly lower efficacy with <20% inhibition (p < .05). Bactericidal effects were the greatest for CHG (log10 reduction of 9.0), followed by OCT (7.7), POL (5.1), and CLO (6.8). MUP, however, showed a very low bactericidal effect of only 2.1. Even when the exposure time was increased to 24 h, 2% MUP did not show sufficient bactericidal effect.The researchers say their data provide evidence that OCT and CHG are effective components for disinfection of MRSA-biofilms. On the other hand, exposure to MUP at the standard concentrations in topical preparations did not effectively inhibit MRSA-biofilms and also did not show adequate bactericidal effects. Combining an MUP-based decolonization regimen with a disinfectant such as OCT or CHG could decrease decolonization failure.Reference: Günther F, et al. MRSA decolonization failure-are biofilms the missing link? Antimicrobial Resistance & Infection Control. 2017;6:32

Recent Videos
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Anna Castillo-Gutierrez, CRCST, CSPDT, CHL, CIS, CFER,  and Maya Luera, CRCST, CIS, CER, CHL
Chase Elms, BS, CRCST
Garrett Hollembeak, CRCST, CIS, CHL, CER, CIC
Hannah Schroeder, BSHA, CRCST, CIS, CHL, CER,
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Related Content

Measles  (Adobe Stock)

Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions

Infection Control Today® Editorial Staff
May 29th 2025
Article

As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.


Sterile Processing Perspectives with Marjorie Wall, EDBA, MLOS, MS, CRCST, CIS, CHL, CSSBB

Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization

Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB ;Rhashamekia Law, MBA, BA, CSPDT, CSPDM;Sandra Hilliard, CHL, CRCST, CIS
May 16th 2025
Article

Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.


Simone Godwin, DVM, MPH, CIC

Non-tuberculous Mycobacterium Outbreak at Surgery Center Highlights Infection Control Lapses

Alexander Sundermann, DrPH, CIC, FAPIC
May 13th 2025
Article

A rare Tennessee outbreak of Mycobacterium fortuitum revealed deep gaps in infection prevention at outpatient surgery centers—where oversight, staffing, and reporting often fall short.


Endoscopy at the hospital. Doctor holding endoscope before gastroscopy  (Adobe Stock by romaset)

Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks

Alexander Sundermann, DrPH, CIC, FAPIC
May 7th 2025
Article

Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.


Elizabeth (Betty) Casey, MSN RN CNOR CRCST CHL

From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing

Tori Whitacre Martonicz
April 27th 2025
Article

Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.


Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB

A Chat With Marjorie Wall, EDBA: Human Factors, Innovation, and Collaboration for Safer Patient Outcomes in the SPD

Tori Whitacre Martonicz
April 25th 2025
Article

Sterile processing departments face high-stakes challenges daily. At AORN 2025, Marjorie Wall outlined transformative strategies to improve safety, efficiency, and cross-departmental collaboration, and also discussed HSPA 2025.

Related Content

Measles  (Adobe Stock)

Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions

Infection Control Today® Editorial Staff
May 29th 2025
Article

As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.


Sterile Processing Perspectives with Marjorie Wall, EDBA, MLOS, MS, CRCST, CIS, CHL, CSSBB

Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization

Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB ;Rhashamekia Law, MBA, BA, CSPDT, CSPDM;Sandra Hilliard, CHL, CRCST, CIS
May 16th 2025
Article

Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.


Simone Godwin, DVM, MPH, CIC

Non-tuberculous Mycobacterium Outbreak at Surgery Center Highlights Infection Control Lapses

Alexander Sundermann, DrPH, CIC, FAPIC
May 13th 2025
Article

A rare Tennessee outbreak of Mycobacterium fortuitum revealed deep gaps in infection prevention at outpatient surgery centers—where oversight, staffing, and reporting often fall short.


Endoscopy at the hospital. Doctor holding endoscope before gastroscopy  (Adobe Stock by romaset)

Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks

Alexander Sundermann, DrPH, CIC, FAPIC
May 7th 2025
Article

Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.


Elizabeth (Betty) Casey, MSN RN CNOR CRCST CHL

From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing

Tori Whitacre Martonicz
April 27th 2025
Article

Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.


Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB

A Chat With Marjorie Wall, EDBA: Human Factors, Innovation, and Collaboration for Safer Patient Outcomes in the SPD

Tori Whitacre Martonicz
April 25th 2025
Article

Sterile processing departments face high-stakes challenges daily. At AORN 2025, Marjorie Wall outlined transformative strategies to improve safety, efficiency, and cross-departmental collaboration, and also discussed HSPA 2025.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News